BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6407295)

  • 1. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
    Cerdá E; Esteban A; de la Cal MA; Fernández A; García A
    Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
    Tuxen DV; Powles AC; Mathur PN; Pugsley SO; Campbell EJ
    Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
    Priebe HJ
    Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity.
    Kieler-Jensen N; Milocco I; Ricksten SE
    J Heart Lung Transplant; 1993; 12(2):179-84. PubMed ID: 8476888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
    Cockrill BA; Kacmarek RM; Fifer MA; Bigatello LM; Ginns LC; Zapol WM; Semigran MJ
    Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Dal Nogare AR; Rubin LJ
    Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
    Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
    Konstam MA; Salem DN; Isner JM; Zile MR; Kahn PC; Bonin JD; Cohen SR; Levine HJ
    Am J Cardiol; 1984 Jul; 54(1):132-6. PubMed ID: 6430055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
    Geggel RL; Dozor AJ; Fyler DC; Reid LM
    Am Rev Respir Dis; 1985 Apr; 131(4):531-6. PubMed ID: 3994148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
    Priebe HJ
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right-ventricular contractility in chronic obstructive pulmonary disease: a combined radionuclide and hemodynamic study.
    Burghuber OC; Bergmann H
    Respiration; 1988; 53(1):1-12. PubMed ID: 3387685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine.
    Brent BN; Matthay RA; Mahler DA; Berger HJ; Zaret BL; Lister G
    Am Rev Respir Dis; 1984 May; 129(5):682-6. PubMed ID: 6721268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central hemodynamics and right ventricular function after coronary artery bypass surgery. A comparison of prostacyclin, sodium nitroprusside, and nitroglycerin for treatment of postcardiac surgical hypertension.
    Kieler-Jensen N; Houltz E; Milocco I; Ricksten SE
    J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):555-9. PubMed ID: 8268436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does salbutamol improve the ventricular performance in patients with chronic obstructive pulmonary disease?
    Mols P; Ham H; Naeije N; Dechamps P; Huynh CH; Vandenbosch L; Sergysels R
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):127-33. PubMed ID: 2459542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.